Show me and others some of the fabled "litany of comments over the last 4 years that any day J&J would form a partnership". Any day? Really? So I was continuously suggesting (in a litany of comments) J&J would forego seeing the results of a clinical trial it is sponsoring and just do a partnership anyway....any day? Interesting, I must have forgotten that premise.
Your constant unhelpful whining is one thing, but making up lies about me too?
What I do Mangoman is go to some effort to post informative comments and insights on the wider developments in the stem cell sphere, particularly regulatory and commercial partnership developments overseas, that have implications for OCC, that help OCC investors to be a little better informed as to its prospects.
You keep posting baseless, unevidenced claims like "From one mango to another, J&J is a touchy subject. It vanished into thin air I expect." I will keep posting pertinent information and yes often add a little enthusiasm being a grateful ATI patient as I have explained in detail for others benefit, excuse me if I get a tad hopeful of a J&J deal so thousands of others can benefit.
I am still near 75% confident of a deal emerging - and that was originally a quite open admission that I considered OCC a collection of call options on its products and pathways, with ATI having a 75% delta, thanks for quoting out of context. The Striate call option now nigh on 100%, hence OCC is trading $0.50 you might have noticed.
@jackphil I, and others I am sure, would love to get some objective input from you on ATI (and move beyond this negative crap). I had to go down into the nitty gritty of the pathophysiology of tendinosis and ATI's MOA (method of actions) in response to a few posters trying to discredit the science (that informed OCC/J&J researchers, biochemists and surgeons are obviously actually misinformed on ). You far superior insights gratefully received (with your PhD in collagen/connective tissues). I have personally posted many times my frustrations with the academic world being somewhat oblivious to OCC's progress and citing preclinical steps with tenocytes in tendinosis, when they have published human trial success. You must share some frustration there?
). You far superior insights gratefully received (with your PhD in collagen/connective tissues). I have personally posted many times my frustrations with the academic world being somewhat oblivious to OCC's progress and citing preclinical steps with tenocytes in tendinosis, when they have published human trial success. You must share some frustration there?
(20min delay)